Larimar Therapeutics, Inc. (LRMR)

Larimar Therapeutics Market Cap

Larimar Therapeutics has a market cap or net worth of $410.87 million as of April 26, 2024. Its market cap has increased by 97.82% in one year.

• Market Cap: 410.87M
• Enterprise Value: 328.29M
• 1-Year Change: 97.82%
• Ranking: #3101
• Category: Small-Cap
• Stock Price: $6.44

Market Cap Chart

Since June 19, 2014, Larimar Therapeutics's market cap has decreased from $410.90M to $410.87M, a decrease of -0.01%. That is a compound annual growth rate of -0.00%.

Market Cap History

Date	Market Cap	% Change
Apr 26, 2024	410.90M	1.73%
Apr 25, 2024	403.90M	-1.99%
Apr 24, 2024	412.10M	-
Apr 23, 2024	412.10M	0.93%
Apr 22, 2024	408.30M	-1.99%
Apr 19, 2024	416.60M	2.36%
Apr 18, 2024	407.00M	-9.52%
Apr 17, 2024	449.80M	-2.62%
Apr 16, 2024	461.90M	-0.82%
Apr 15, 2024	465.70M	4.89%
Apr 12, 2024	444.00M	-3.60%
Apr 11, 2024	460.60M	5.55%
Apr 10, 2024	436.40M	-2.85%
Apr 9, 2024	449.20M	-2.48%
Apr 8, 2024	460.60M	-2.97%
Apr 5, 2024	474.70M	2.35%
Apr 4, 2024	463.80M	-5.83%
Apr 3, 2024	492.50M	4.88%
Apr 2, 2024	469.60M	-1.32%
Apr 1, 2024	475.90M	-1.71%
Mar 28, 2024	484.20M	4.47%
Mar 27, 2024	463.50M	0.89%
Mar 26, 2024	459.40M	-5.00%
Mar 25, 2024	483.60M	-6.30%
Mar 22, 2024	516.10M	-5.49%

View and export this data all the way back to 2014. Sign Up Today.

Related Stocks

Company	Market Cap
Voyager Therapeutics	413.77M
Acelyrin	412.72M
Nevro	412.02M
Lexeo Therapeutics	411.85M
biote	411.41M
Tourmaline Bio	402.14M
LENZ Therapeutics	401.39M
Travere Therapeutics	400.28M